The Simple Math Behind 63% Savings In Australia
Source: Clinical Leader
Russell Hayward of Etira explains how identical site and patient costs in the U.S. and Australia, combined with currency exchange rates and a 43.5% R&D rebate, reduced his trial budget from $4 million to about $1.5 million. He notes only minor delays, with no major cost surprises.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader